Introduction {#sec1_1}
============

*Mycobacterium ulcerans* infection known as Buruli ulcer (BU) is a neglected tropical disease of the skin. It is prevalent in scattered foci around the world, predominantly in riverine areas with a humid, hot climate. It is an important health problem that occurs in about 33 (mostly tropical) countries, with the greatest frequency reported in Africa, particularly in West African countries. Outside Africa, cases have also been described in Japan, Mexico, South America, Papua New Guinea, and Australia \[[@B1]\]. In Cameroon, *M. ulcerans* infection has been reported in several provinces. The district of Akonolinga was identified as a health district with a high prevalence of BU, in 2007, the overall prevalence being 0.47% \[[@B2]\]. The mode of transmission remains poorly understood; both transmission by insects or direct inoculation by a contaminated environment has been suggested. Lesions are most commonly found on exposed parts of the body, particularly on the limbs. Recommended treatment consists of antibiotic therapy and surgical debridement, followed by skin grafting if necessary. Natural evolution of the disease may lead to spontaneous healing but, in the absence of early detection and appropriate treatment, the disease can extend leaving functional incapacities as some patients can develop osteomyelitis and articular lesions. It is known that *M. ulcerans*produces a toxin, mycolactone, which induces necrosis and ulceration by its cytotoxic and immunosuppressive properties \[[@B3]\].

BU diagnosis remains a challenge in resource-limited countries. Laboratory confirmation of suspected cases prevents misclassification, ensures adequate treatment, and provides reliable incidence and prevalence data that in turn might support the development of new disease strategies \[[@B4]\]. Confirmation of the clinical diagnosis becomes increasingly important to minimize erroneous antibiotic treatment and it is recommended to be used to complement clinical diagnosis \[[@B5]\]. Previously available data on diagnostic tests applied to different specimens suggest a wide range of sensitivities \[[@B6]\]. The Ziehl-Neelsen (ZN) stain detecting alcohol-resistant bacilli in a swab taken from below the undermined edge of the ulcer base shows a low sensitivity rate of 40%. In nonulcerative lesions, ZN stain on fine-needle aspirates can also be used to detect acid-fast bacilli (AFB) \[[@B4], [@B7]\]. Culture of *M. ulcerans* reveals a low sensitivity rate of 35--50% with many false-negative cases, similar to that of direct examination of ZN staining for AFB in smears. Microbial culture is not widely available and takes up to 8 weeks for a result \[[@B4], [@B7]\]. PCR has become a fast and reliable method for the diagnosis of *M. ulcerans* infection in humans, a test whose results can be obtained within 2 days. The PCR for the IS2404 is specific to *M. ulcerans*DNA and is a highly sensitive method to detect *M. ulcerans* in human tissue \[[@B4], [@B6], [@B7]\]. A cohort study, conducted in Ghana between 2006 and 2008, assessed the sensitivity of different laboratory diagnostic tests. Across all subgroups, PCR assessment of 3-mm punch biopsy tissue specimens proved to be the best diagnostic tool for nonulcerated lesions with a sensitivity rate of 85%, and PCR assessment of swab samples was also the best diagnostic tool for ulcerated lesions \[[@B6]\]. This method tends to be implemented in poor rural areas from where transportation is required towards a reference laboratory that can provide strict quality control and a well-trained personnel \[[@B3]\]. Histology mainly performed on excised lesions is more sensitive than culture and ZN stain on smears (63--90%), but surgical excision is often not required when patients are treated with antibiotherapy \[[@B4], [@B8], [@B9]\]. Histological description of BU has mostly been based on case reports \[[@B10], [@B11]\], and only one study, published in 2003, offers a systematic description of the infected tissue on excisional skin biopsy \[[@B8]\]. In this paper, we aim to clarify the main histopathological features of cutaneous BU on 4-mm punch biopsies and to determine the diagnostic value of this method.

Materials and Methods {#sec1_2}
=====================

Between October 2011 and December 2013, a prospective cohort study was conducted in the Akonolinga Health District, central Cameroon \[[@B12]\]. The funder, Médecins Sans Frontières, had a role in the study design and data collection. All individuals presenting at the Akonolinga District Hospital with a suspected cutaneous new BU lesion (defined as either a nodule, plaque, localized swelling and/or an ulcer in an individual residing or having spent at least 1 night in a known endemic area for *M. ulcerans*) were included consecutively. A dermatologist from Yaounde, Central Hospital, visited the project every 2 weeks and saw a subset of the patients. Photographs were taken of all suspected lesions. Two dermatologists reviewed the photographs of all cases independently; the first dermatologist was from Yaounde and the second was an expert in tropical skin diseases in the University Hospital of Geneva in Switzerland (Fig. [1a](#F1){ref-type="fig"}). Dry swabs from ulcerative lesions and fine-needle aspirates of nonulcerative lesions were examined using ZN staining in the Akonolinga Hospital laboratory the day they were collected. Another set of samples was sent weekly to the reference laboratory in Yaounde (Centre Pasteur Cameroon, CPC), where, after pooling of the samples for each lesion, ZN direct examination was repeated, followed by PCR targeting IS2404 and culture. The CPC is part of a BU external quality control program run by the Institute of Tropical Medicine in Antwerp, Belgium. Two 4-mm punch skin biopsies were performed by trained clinicians. On ulcerative lesions, a biopsy was taken at the edge and in the center of the lesion; for nonulcerated lesions, they were taken in the middle of the nodule (although biopsy was optional for these cases). After taking the biopsies, samples were immediately fixed and stored in 4% formaldehyde before being sent to the CPC where specimens were routinely processed and embedded in paraffin blocks. The slides were prepared and were systematically stained with hematoxylin/eosin and ZN. Additional stainings (Giemsa, silver staining) were performed in cases of other clinical suspicion (leishmaniasis, mycotic infection). A first reading of the slides was done in the CPC by a local histopathologist. The slides and the paraffin blocks were then sent to the Pathology Department of the University Hospital of Geneva for a second reading by a histopathologist; if required, additional immunohistochemical analysis was performed (particularly for tumor confirmation). Every slide was assessed for the presence or absence of histopathologic features previously evaluated in definitive and suspected BU cases in past studies \[[@B8]\]: the presence or absence of coagulative dermal and/or subcutaneous necrosis, panniculitis, signs of vasculopathy with vasculitis, +/-- vascular parietal necrosis, +/-- thrombosis, the type of inflammation (acute neutrophilic inflammation, chronic inflammation with lymphocytes +/-- plasma cells or granulomatous inflammation) and the presence or absence of AFB by ZN stain. The histological case definition of "very likely BU" required the presence of diffuse coagulative necrosis of the dermis and/or the subcutis, with a neutrophilic inflammatory infiltrate, with or without AFB detected by ZN stain on histology \[[@B8]\]. All other cases without a definite diagnosis were discussed in consensus meetings that took place by videoconference between Yaounde and Geneva during the course of the study, in the presence of clinicians, dermatologists and pathologists. All clinical information and laboratory results were discussed, and clinicians were asked to estimate the probability of BU on a scale from 0 to 10. Final diagnosis of BU named "consensus diagnosis" was defined as \[[@B12], [@B13]\]: at least two positive laboratory tests (among positive AFB detected by ZN stain in smears in Akonolinga or in CPC, positive *M. ulcerans* DNA detected by PCR in CPC, or positive AFB by ZN stain on histology); or being the most likely diagnosis based on both expert reviews of photographs; or BU agreed upon as the most likely diagnosis during consensus meetings.

In this study, we focused on patients with a final diagnosis of BU by consensus who also had a histological diagnosis of "very likely BU," defined as the presence of diffuse coagulative necrosis of the dermis and/or the subcutaneous tissue, with neutrophilic inflammatory infiltrate, with the presence of AFB on histological samples detected by ZN stain, or without AFB detected by histology but with at least two other positive laboratory tests.

Results {#sec1_3}
=======

Between October 2011 and December 2013, 367 patients were included in the study out of 447 screened and 364 patients were finally analyzed (3 secondary exclusions due to missing clinical data), corresponding to 422 lesions of which 381 were ulcerative (90.3%). Detailed patient flow is presented elsewhere \[[@B13]\]. 357 lesions were biopsied and had a pathological examination in CPC in Yaounde (350 were ulcerative and 7 were nonulcerative). Only 353 lesions were analyzed in the Pathology Department of Geneva University Hospitals, as 4 lesions could not have pathological results although there was a biopsy (either because the slides were not sent, or they were of too low quality to be analyzed or the sample was judged too superficial to be assessed).

Histological Diagnosis {#sec2_1}
----------------------

From the 353 ulcerated and nonulcerated lesions analyzed in Geneva University Hospitals, nonspecific ulcer was the most frequent histological diagnosis in more than half of the punch biopsies analyzed (190/353 = 53.8%), followed by non-BU infectious lesions (especially bacterial skin infection, 5.7%), "very likely BU lesions" (44/353, 12.5%), mixed vascular/venous ulcers (23.2%), and neoplastic lesions (17/353, 4.8%) including 7 squamous cell carcinomas, 7 Kaposi sarcomas, and 3 other malignant tumors (chondrosarcoma, myxoid fibrosarcoma, and leiomyosarcoma) \[[@B13]\].

Final Consensus Diagnosis of BU {#sec2_2}
-------------------------------

After combining consensus meetings, laboratory and clinical results, a final consensus diagnosis of BU was retained in 113/422 ulcerated and nonulcerated lesions affecting 99/364 patients (27.2%). When restricting the analysis to ulcerative lesions, final consensus diagnosis of BU was estimated in 99/381 ulcerated lesions (25.9%) corresponding to 87/327 patients (26.6%).

Histopathologically Confirmed BU Cases {#sec2_3}
--------------------------------------

In this study, we focused on ulcerated lesions with a final diagnosis of BU by consensus also having a histological diagnosis of "very likely BU." From the 99 ulcerated BU lesions confirmed by consensus, histological features for BU were fulfilled in 32 lesions, biopsied from 31 patients corresponding to a sensitivity rate of 32.3%. Epidermal regeneration and subcutaneous necrosis (Fig. [1b](#F1){ref-type="fig"}) were seen in all lesions as well as acute neutrophilic inflammatory infiltrate (32/32) (Fig. [1c](#F1){ref-type="fig"}). Ghost cells could be seen in 75% of BU lesions (24/32). Most showed signs of vasculopathies (28/32), some with thrombi (12/32) and many with vasculitis (28/32). 30/32 showed parietal necrosis of superficial vessels, most probably secondary to the ulcerative status of the lesions. 26/32 presented alcohol-resistant bacilli confirmed by ZN stain on histological examination (Fig. [1d](#F1){ref-type="fig"}). The results of histological analysis of the 32 BU lesions are shown in Table [1](#T1){ref-type="table"}. The 6 cases without alcohol-resistant bacilli by ZN stain had at least two positive laboratory tests for *M. ulcerans*: ZN stain on swabs or on fine-needle aspirates, culture or PCR results (Table [2](#T2){ref-type="table"}). 15/32 showed a positive culture for *M. ulcerans.* AFB in swab samples were detected in 25/32 cases. *M. ulcerans* DNA was identified by PCR in 31/32 cases and PCR was shown to have a sensitivity rate of 94% \[[@B13]\]. 31 of them were localized in the upper and lower extremities, only 1 was present on the trunk. 9 patients were HIV positive. The clinical features of histologically confirmed BU patients are shown in Table [3](#T3){ref-type="table"}.

Amongst the 67 remaining ulcerated lesions with a final consensus diagnosis of BU, 10/67 did not have any histological results, and the remaining 57 lesions showed the following histological features: absence of AFB by ZN stain (57/57), presence of focal coagulative necrosis of dermis +/-- subcutis (32/57), presence of a chronic lymphocytic inflammatory infiltrate (25/57) or a neutrophilic inflammatory infiltrate (10/57), with sometimes some signs of vasculopathy probably secondary to the ulcerative status (14/57).

Discussion {#sec1_4}
==========

Based on the systematic histological examination of the 32 definite BU lesions, the most reliable histopathological feature for the diagnosis of BU in ulcerated lesions by using 4-mm punch biopsies is diffuse coagulative necrosis of dermis +/-- subcutaneous tissue with a neutrophilic inflammatory infiltrate and the presence of AFB detected by ZN stain \[[@B4], [@B13], [@B15]\]. The subcutaneous tissue necrosis found in such cases has been attributed to an extracellular toxin, a polyketide-derived macrolide, called mycolactone, that is produced by *M. ulcerans*. Once the organism is introduced in the subcutaneous tissue, it proliferates and elaborates this toxin that has an affinity for fat cells. It has both cytotoxic and immunosuppressive properties resulting in necrosis and providing a favorable milieu for further proliferation of the organism. As these histological features are nonspecific and may change as the lesion evolves from a nodule to an ulcer, diagnosis of BU requires correlation with clinical data and other laboratory results \[[@B8]\].

Confirmation of clinically suspected cases of BU is based on the presence of any two of the following laboratory findings: presence of AFB in a smear stained by the ZN technique, positive culture of *M. ulcerans* from the infected tissue, histopathological study of the excisional biopsy specimen and evidence of *M. ulcerans* DNA by the PCR technique \[[@B5], [@B9], [@B14]\]. Recently, researchers have devised a new rapid diagnostic test using fluorescent thin-layer chromatography to selectively detect mycolactone. This simple and rapid test was identified as a promising technique and has the potential to become an important tool for field workers involved in BU case detection and treatment at the district level. Further studies are planned to address the logistics of introducing this test to endemic countries, to confirm its sensitivity and to investigate its specificity \[[@B18]\].

Our study revealed that histopathology has a sensitivity rate of 32.3% in diagnosing BU in punch biopsies of ulcerated lesions. This sensitivity is rather representative of the diagnosis of BU in endemic areas in a context of a large recruitment of cases \[[@B5]\]. Histopathology is a useful method for monitoring unexpected response to treatment \[[@B16]\] and for establishing differential diagnosis \[[@B17]\]. In our study, histological examination of biopsy specimens was helpful in the diagnosis of other entities presenting as cutaneous ulcers, particularly malignant neoplasia (squamous cell carcinoma, Kaposi sarcoma, leiomyosarcoma, myxoid fibrosarcoma, and chondrosarcoma) \[[@B13]\]. Histologic analysis also helped in diagnosing non-BU infectious ulcers and mixed vascular ulcers \[[@B13]\]. Punch biopsies can be easily performed in endemic areas by well-trained medical teams, and histology may be used for research purposes especially in studying the pathophysiology of paradoxical reactions and understanding the absence of response to treatments \[[@B16]\]. The era of performance of large surgical excisions is actually almost over with the development of earlier methods of diagnosis and early efficient medical management.

Histopathological analysis has some drawbacks as it requires an experienced laboratory relatively close to the care center and it is also quite expensive to perform \[[@B3]\]. The diagnostic value of punch biopsies is sometimes limited, and false-negative results could happen when samples are too superficial. Moreover, marks of traditional medicine applied in wounds before sampling have interfered with the diagnosis. Also, samples may suffer from technical problems during each step of preparation up to the analysis of slides. In summary, although histopathology is not as sensitive as PCR in diagnosing BU, histopathological analysis of suspected BU lesions by using 4-mm punch biopsies in the center and in the periphery of the lesions, by adding the ZN stain, can help in providing the correct diagnosis of BU. Our study shows that the most reliable histopathological features for diagnosing ulcerated BU disease on punch biopsies are diffuse necrosis of the dermis +/-- subcutaneous tissue with neutrophilic inflammatory infiltrate and the presence of AFB by ZN stain. However, the histological changes are not unique, and diagnosis requires correlation with the clinical picture and other laboratory techniques. Histopathology also remains one of the best tools for establishing the differential diagnosis of chronic ulcers in endemic areas.
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![**a** Clinical photography of a BU of the dorsum of the foot. **b** Edge of a BU at low magnification (×20), showing a coagulative dermal and subcutaneous necrosis (hematoxylin/eosin stain). **c** High magnification (×200), showing subcutaneous necrosis and acute neutrophilic inflammatory infiltrate (hematoxylin/eosin stain). **d** Alcohol-resistant bacilli confirmed by ZN stain (original magnification, ×400).](dpa-0006-0028-g01){#F1}

###### 

Histopathologic features of 32 confirmed BU lesions

  Histopathologic features     *n*     \%
  ---------------------------- ------- ------
  Subcutaneous tissue                  
   Coagulative necrosis        32/32   100
   Ghost cells                 24/32   75
  Inflammation                         
   Neutrophilic                32/32   100
   Lymphocytic                 10/32   31.2
   Eosinophilic                18/32   56.2
  Granulomas                   2/32    6.2
  Vasculitis                   28/32   87.5
   Thrombosis                  12/32   37.5
   Necrosis of vascular wall   30/32   93.7
  AFB (ZN stain)               26/32   81.2

###### 

Laboratory results of the 6 confirmed BU cases without alcohol-resistant bacilli by ZN stain on histology

  Case No.   PCR   ZN stain on swab in   Culture   
  ---------- ----- --------------------- --------- ----
  3          \+    --                    \+        --
  5          \+    \+                    --        \+
  14         \+    \+                    --        --
  19         \+    \+                    --        \+
  24         \+    \+                    \+        --
  25         \+    \+                    --        --

###### 

Clinical features of histologically confirmed BU patients

  Patient   Sex      Age, years   History of trauma   HIV   Site       Clinical form   Size, cm
  --------- -------- ------------ ------------------- ----- ---------- --------------- ----------
  1         male     18           \+                  --    foot       ulcer           5×3
  2         male     11           \+                  --    ankle      ulcer           10×7
  3         female   10           --                  --    thorax     ulcer           10×8
  4         female   16           \+                  --    ankle      ulcer           4×2
  5         female   16           --                  --    forearm    ulcer           1×1
  6         male     10           \+                  --    foot       ulcer           15×10
  7         male     3            --                  --    calf       ulcer           3×2
  8         female   3            --                  --    leg        ulcer           1×1
  9         male     31           --                  \+    leg        ulcer           8×7
  10        female   20           --                  --    ankle      ulcer           2×2
                                                                                       
  11        female   9            --                  --    calf       ulcer           2×1
  12        male     23           \+                  --    hand       ulcer           3×1
  13        male     6            --                  --    leg        ulcer           4×4
  14        male     39           --                  --    elbow      ulcer           2×2
  15        male     10           --                  --    calf       ulcer           1×1
  16        female   25           --                  \+    forearm    ulcer           7×5
                                                            knee       ulcer           2×1
  17        female   47           --                  \+    buttocks   ulcer           20×10
  18        female   73           \+                  --    ankle      ulcer           10×5
  19        male     11           --                  --    elbow      ulcer           7×6
  20        male     11           --                  --    ankle      ulcer           5×3
                                                                                       
  21        female   85           --                  --    calf       ulcer           3×2
  22        male     42           \+                  \+    calf       ulcer           4×4
  23        female   56           --                  \+    foot       ulcer           30×10
  24        female   6            --                  --    calf       ulcer           15×15
  25        female   14           --                  --    arm        ulcer           16×10
  26        male     45           --                  \+    leg        ulcer           17×12
  27        male     32           --                  \+    foot       ulcer           2×1
  28        female   12           \+                  --    ankle      ulcer           3×2
  29        female   6            --                  --    ankle      ulcer           4×3
  30        male     27           --                  --    leg        ulcer           8×6
  31        male     66           \+                  \+    ankle      ulcer           7×7
